loadpatents
name:-0.025166988372803
name:-0.021964073181152
name:-0.0088851451873779
Hajduch; Marian Patent Filings

Hajduch; Marian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hajduch; Marian.The latest application filed is for "molecular complex assembly particles comprising bis-r1,r2-dithiocarbamate-metal complex and a ligand, method of preparation and use thereof".

Company Profile
9.19.21
  • Hajduch; Marian - Moravsky Beroun CZ
  • HAJDUCH; Marian - Moravsk Beroun CZ
  • Hajduch; Marian - Moravsky Beraun CZ
  • Hajduch; Marian - Olomouc CZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted pyridopyrrolopyrimidine ribonucleosides for therapeutic uses
Grant 11,299,510 - Veselovska , et al. April 12, 2
2022-04-12
Molecular Complex Assembly Particles Comprising Bis-r1,r2-dithiocarbamate-metal Complex And A Ligand, Method Of Preparation And Use Thereof
App 20220000914 - MISTRIK; Martin ;   et al.
2022-01-06
Method Of Identification Of Entities From Mass Spectra
App 20210241851 - HRUSKA; Miroslav ;   et al.
2021-08-05
Substituted Pyridopyrrolopyrimidine Ribonucleosides For Therapeutic Uses
App 20210002321 - VESELOVSKA; Lucia ;   et al.
2021-01-07
Bioavailable Dithiocarbamate-metal Complex Particles, Method Of Preparation And Use Thereof
App 20200276124 - SKROTT; Zdenek ;   et al.
2020-09-03
15.beta.-substituted estrone derivatives as selective inhibitors of 17.beta.-hydroxysteroid-dehydrogenases, method of preparation and use thereof
Grant 10,759,826 - Kotora , et al. Sep
2020-09-01
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
Grant 10,730,905 - Hocek , et al.
2020-08-04
15beta-substituted estrone derivatives as selective inhibitors of 17beta-hydroxysteoid-dehydrogenases, method of preparation and
App 20190330258 - KOTORA; Martin ;   et al.
2019-10-31
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use
Grant 10,414,788 - Hocek , et al. Sept
2019-09-17
Substituted Thienopyrrolopyrimidine Ribonucleosides For Therapeutic Use
App 20190144487 - HOCEK; MICHAL ;   et al.
2019-05-16
Substituted Heteropentadieno-pyrrolopyrimidine Ribonucleosides For Therapeutic Use
App 20190144486 - HOCEK; Michal ;   et al.
2019-05-16
Method Of Predicting The Tumor Response To Dna Methylation Inhibitors And Alternative Therapeutic Regimen For Overcoming Resistance
App 20180251847 - AGRAWAL; Khushboo ;   et al.
2018-09-06
Substituted 7-deazapurine ribonucleosides for therapeutic uses
Grant 9,586,986 - Hocek , et al. March 7, 2
2017-03-07
Novel Substituted 7-deazapurine Ribonucleosides For Therapeutic Uses
App 20160159844 - HOCEK; Michal ;   et al.
2016-06-09
Carbonic anhydrase inhibitors and method of their production
Grant 9,290,529 - Brynda , et al. March 22, 2
2016-03-22
Method Of Determination Of Cancer Cell Drug Sensitivity Towards Aurora Kinase Inhibitors
App 20140336073 - Kollaredy; Madhusudhan Reddy ;   et al.
2014-11-13
Carbonic Anhydrase Inhibitors And Method Of Their Production
App 20140303390 - Brynda; Jiri ;   et al.
2014-10-09
Triterpenoid 2-deoxy glycosides, method of preparation thereof and use thereof as medicaments
Grant 8,680,251 - {hacek over (S)}arek , et al. March 25, 2
2014-03-25
Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation
Grant 8,653,056 - Sarek , et al. February 18, 2
2014-02-18
Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy
Grant 8,465,936 - Hajduch , et al. June 18, 2
2013-06-18
Derivatives of 2-phenyl-3-hydroxyquinoline-4(1H)-one and methods of their preparation and utilization
Grant 8,299,092 - Krejci , et al. October 30, 2
2012-10-30
Method of preparation and isolation of betulin diacetate from birch bark from paper mills and its optical processing to betulin
Grant 8,093,413 - Sarek , et al. January 10, 2
2012-01-10
Triterpenoid 2-deoxy Glycosides, Method of Preparation Thereof and Use Thereof as Medicaments
App 20110218167 - Sarek; Jan ;   et al.
2011-09-08
Method For Determining The Sensitivity Of Patients Suffering From A Cancer Disease To Biological Therapy
App 20110014637 - Hajduch; Marian ;   et al.
2011-01-20
Triterpenoid derivatives
Grant 7,858,606 - Hajduch , et al. December 28, 2
2010-12-28
Triterpenoid derivatives
Grant 7,749,988 - Hajduch , et al. July 6, 2
2010-07-06
Derivatives Of 2-phenyl-3-hydroxyquinoline-4(1h)-one And Methods Of Their Preparation And Utilization
App 20100022587 - Krejci; Petr ;   et al.
2010-01-28
Method Of Preparation Of A Soluble Formulation Of Water-insoluble Pentacyclic And Tetracyclic Terpenoids, A Soluble Formulation Of A Pentacyclic Or Tetracyclic Terpenoid And A Pharmaceutical Composition Containing This Soluble Formulation
App 20090325919 - Sarek; Jan ;   et al.
2009-12-31
Method Of Preparation And Isolation Of Betulin Diacetate From Birch Bark From Paper Mills And Its Optional Processing To Betulin
App 20090318719 - Sarek; Jan ;   et al.
2009-12-24
Triterpenoid derivatives
App 20060160890 - Hajduch; Marian ;   et al.
2006-07-20
Triterpenoid derivatives
Grant 7,041,701 - Hajduch , et al. May 9, 2
2006-05-09
Triterpenoid derivatives
App 20040266868 - Hajduch, Marian ;   et al.
2004-12-30
Triterpenoid derivatives
App 20040087560 - Hajduch, Marian ;   et al.
2004-05-06
Cyclin dependent kinase inhibitor
Grant 6,703,395 - Havlicek , et al. March 9, 2
2004-03-09
Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
App 20030191086 - Hanus, Jan ;   et al.
2003-10-09
Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
Grant 6,552,192 - Hanus , et al. April 22, 2
2003-04-22
Cyclin dependent kinase inhibitor
App 20020065293 - Havlicek, Libor ;   et al.
2002-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed